|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Marketable securities | ||||||||||||||||||||
| Notes receivable from Seastar Medical Holding Corporation (Note 5) | ||||||||||||||||||||
| Less: Allowance for credit loss reserve on notes receivable from Seastar Medical Holding Corporation (Note 5) | ||||||||||||||||||||
| Receivable from sale of Symbiont assets (Note 7) | ||||||||||||||||||||
| Current portion of notes receivable | ||||||||||||||||||||
| Tech Infrastructure JV I LLC | ||||||||||||||||||||
| Total current portion of notes receivable | ||||||||||||||||||||
| Prepaid expenses and other assets | ||||||||||||||||||||
| Finance receivables | ||||||||||||||||||||
| Digital assets - current (Note 2) | ||||||||||||||||||||
| Digital assets - collateral (Note 2) | ||||||||||||||||||||
| Digital assets receivable, net (Note 2) | ||||||||||||||||||||
| Galaxy loan derivative asset (Note 4) | ||||||||||||||||||||
| Income tax receivable | ||||||||||||||||||||
| Current assets | ||||||||||||||||||||
| Fixed assets, net (Note 3) | ||||||||||||||||||||
| Intangible assets, net (Note 3) | ||||||||||||||||||||
| Deposits on mining equipment | ||||||||||||||||||||
| Hosting services deposits (Note 4) | ||||||||||||||||||||
| Real estate assets owned | ||||||||||||||||||||
| Notes receivable net of current portion | ||||||||||||||||||||
| SeaStar Medical | ||||||||||||||||||||
| Tech Infrastructure JV I LLC | ||||||||||||||||||||
| Total notes receivable net of current portion | ||||||||||||||||||||
| Long-term investments - equity securities (Note 6) | ||||||||||||||||||||
| Investment in Seastar Medical Holding Corporation | ||||||||||||||||||||
| Symbiont intangible assets, net (Note 11) | ||||||||||||||||||||
| Digital assets - long-term (Note 2) | ||||||||||||||||||||
| Operating lease - right of use assets (Note 7) | ||||||||||||||||||||
| Right of use assets (Note 5) | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Long-term assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and stockholders' equity | ||||||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||||||
| Note payable - short-term (Note 4) | ||||||||||||||||||||
| Master digital currency loan (Note 4) | ||||||||||||||||||||
| Due to related parties (Note 7) | ||||||||||||||||||||
| Current portion of lease liability (Note 7) | ||||||||||||||||||||
| Galaxy loan derivative liability (Note 6) | ||||||||||||||||||||
| Current portion of lease liability (Note 5) | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Note payable - long-term (Note 4) | ||||||||||||||||||||
| Lease liability - net of current portion (Note 7) | ||||||||||||||||||||
| Lease liability - net of current portion (Note 5) | ||||||||||||||||||||
| Long-term liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders' equity (Note 6) | ||||||||||||||||||||
| Preferred stock, par value $.001; 150,000,000 shares authorized; no shares issued and outstanding as of June 30, 2026 and December 31, 2025 | ||||||||||||||||||||
| Common stock, par value $.001; 350,000,000 shares authorized; 934,662 and 564,940 shares issued and outstanding as of June 30, 2026 and December 31, 2025 | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total PowerCompute stockholders' equity | ||||||||||||||||||||
| Non-controlling interest | ||||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||||
Loading...